References
- Benson M, Teague S, Kovacs R, et al. Rate of progression of transthyretin amyloidosis. Am J Cardiol. 2011;108:285–289.
- Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid poly neuropathy: a clinicopathologic study. Neurology. 1984;34:1025–1025.
- Coelho T, Maia L, Martins da Silva A, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial. Neurology. 2012;79:785–792.
- Novak P. Electrochemical skin conductance: a systematic review. Clin Auton Res. 2017. DOI:10.1007/s10286-017-0467-x
- Planté-Bordeneuve V, Gorram F, Salhi H, et al. Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study. J Neurol. 2017;264:268–276.